《大行》大摩:保險產品預定利率上限下調 紓緩內險利率風險疑慮
大摩發表報告指,中保協最新公布的預定利率研究值為1.99%,低於4月的2.13%和1月的2.34%,顯示利率持續下降。多家保險公司宣布在8月底前進一步下調利率,普通型產品從2.5%降至2%,分紅型產品從2%降至1.5%,萬能型產品從1.5%降至1%。
報告指,自2023年下半年以來,監管機構和保險公司已採取一系列措施減輕利差損失風險,預計這一趨勢將持續。8月後,保險公司新資金流入的保證負債成本預計將降至約1.7%,可提高盈利能力,相對目前長期利率高於1.7%。
該行指,保險公司表現強勁的關鍵驅動因素包括近期利率上調、穩健的2025年上半年業績預告,以及有利的市場情緒和資金流向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.